Where to Inject BPC-157: Sites & Technique
BPC-157 is a subcutaneous injection. The four standard sites all work, but the questions patients actually ask are whether to inject near the injury, how to rotate, and how to do it without a stinging welt. Here is the practical guide people want after the first vial arrives.

In this article
Key Takeaways
- BPC-157 is a subcutaneous injection, not intramuscular. The needle enters the fat layer just beneath the skin at a 45 to 90 degree angle.
- Four standard sites: abdomen (at least two inches from the navel), front or outer thigh, upper outer glute, and the back of the deltoid. The abdomen is the most common.
- You can inject subcutaneously in the general area of a soft-tissue injury (for example, near an injured Achilles or elbow) if the tissue there has fat to pinch. It still enters circulation, so it is not a true local injection.
- Rotate at least one inch from your last injection point every time, and rotate body regions every few injections to avoid nodules and irritation.
- Use a 27 to 31 gauge insulin syringe, 1/2 inch length. Volume is small, usually 0.1 to 0.3 mL. Always follow the dose your provider prescribed, not a protocol you found online.
BPC-157 Injection Quick Facts
Route
Subcutaneous (under the skin, not into muscle)
Standard Sites
Abdomen, thigh, upper glute, back of deltoid
Most Common Site
Abdomen (consistent absorption, easy to see)
Needle
27-31 gauge insulin syringe, 1/2 inch length
Volume
Small, typically 0.1-0.3 mL per injection
Ships
Fully reconstituted and ready to use, no mixing
BPC-157 Is a Subcutaneous Injection
BPC-157 is a subcutaneous (subQ) injection. The needle goes into the fat layer just beneath the skin, not into muscle. If peptides are new to you, what peptide therapy is covers the basics first, and the full how-to-inject-peptides guide walks through subQ technique from scratch. This guide is narrower: where to put BPC-157, whether it matters that you inject near an injury, and how to do it cleanly. For how the peptide works and how dosing is structured, see the main BPC-157 guide.
The Four Standard Sites
There are four anatomical regions any subQ peptide injection can use, BPC-157 included. Each has slightly different fat coverage and ergonomics.
1. Abdomen. The area between the lower rib cage and the hip bones, avoiding a roughly two-inch radius around the navel. This is the default for most patients. Fat coverage is consistent, the area is easy to see, and absorption is reliable. Use the soft tissue on either side of the belly button rather than directly above or below it.
2. Front or outer thigh. The middle third of the thigh, on the front (anterior) or outer (lateral) side. The fat layer is usually adequate here and the angle is comfortable for self-injection while seated. Avoid the inner thigh, which is more vascular, and stay clear of the knee and hip.
3. Upper outer glute. The upper outer quadrant of the buttock, the same region used for many vaccinations. It is harder to reach without a mirror, but fat coverage tends to be deepest here and absorption is excellent. Many patients rotate this site in once or twice a week to give the abdomen a rest.
4. Back of the deltoid. The fat pad on the back of the upper arm, just behind the deltoid muscle. Coverage varies a lot between people. If you can pinch a half-inch or more of skin and fat, it works. If the skin pulls tight against muscle, pick a different region.
Practical Default
Use the abdomen as your primary site. Rotate to thigh or glute every few injections. Skip the deltoid unless you have clear fat coverage there.
Should You Inject Near the Injury?
This is the question that separates BPC-157 from most other peptides people inject. Because BPC-157 is best known for soft-tissue and tendon recovery, a lot of patients want to inject it right at the sore Achilles, elbow, or knee, assuming the peptide will concentrate where it is needed.
Here is the honest version. A subcutaneous injection still enters the bloodstream and acts systemically. So injecting into the fat near an injured area is not a true targeted local injection the way a cortisone shot into a joint is. Much of the preclinical BPC-157 research on tendon and ligament healing used systemic dosing, not injection into the injured structure.
Chang CH et al., "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration," Journal of Applied Physiology, 2011 (cell-culture and animal study). View study
That said, injecting subcutaneously in the general region of the injury is fine and common, as long as there is enough loose skin and fat to pinch and the skin there is clean and unbroken. Many people inject into the fat of the outer thigh when the target is the knee, for example. What you should never do is push the needle into a tendon, a joint capsule, or muscle yourself. That is not the BPC-157 protocol, and it is a job for a clinician, not a home injection.
Gwyer D et al., "Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing," Cell and Tissue Research, 2019 (review of preclinical evidence). View study
The Short Answer
Injecting subQ near the injury is reasonable and does no harm if the tissue has fat to pinch, but it works systemically either way. If reaching the area is awkward, the abdomen is just as valid. Follow the site guidance your provider gave you.
Subcutaneous vs Intramuscular
BPC-157 is prescribed and shipped as a subcutaneous medication. Some online forums debate intramuscular (IM) injection, usually with the same near-the-injury logic as above. For home use, subcutaneous is the standard route for a few practical reasons.
| Factor | Subcutaneous (subQ) | Intramuscular (IM) |
|---|---|---|
| Needle | Short insulin needle, 1/2 inch | Longer needle, deeper insertion |
| Ease of self-injection | Simple, pinch and inject | Harder to place safely alone |
| Soreness and bruising | Usually minimal | More common |
| What PeRx ships for | This is the intended route | Not the prescribed route |
Needle
- Subcutaneous (subQ)
- Short insulin needle, 1/2 inch
- Intramuscular (IM)
- Longer needle, deeper insertion
Ease of self-injection
- Subcutaneous (subQ)
- Simple, pinch and inject
- Intramuscular (IM)
- Harder to place safely alone
Soreness and bruising
- Subcutaneous (subQ)
- Usually minimal
- Intramuscular (IM)
- More common
What PeRx ships for
- Subcutaneous (subQ)
- This is the intended route
- Intramuscular (IM)
- Not the prescribed route
Unless your provider specifically instructs otherwise, inject BPC-157 subcutaneously with the insulin syringes included in your order. It is easier, it hurts less, and it is what the dose and packaging assume.
How to Inject, Step by Step
The general subQ technique is the same for BPC-157 as for any PeRx peptide. If you want the fully illustrated version, use the how-to-inject-peptides guide. Here is the short sequence.
1. Wash your hands and gather supplies. Insulin syringe, alcohol swab, your BPC-157 vial, and a sharps container. Everything you need ships in the box.
2. Let the vial come up from cold. Take the vial out of the fridge a few minutes before injecting. Cold solution stings more going in. Do not heat it; a few minutes on the counter is enough.
3. Inspect and draw. The solution should be clear, not cloudy or discolored. Wipe the rubber stopper with an alcohol swab, then draw your prescribed dose. The volume is small, often 0.1 to 0.3 mL, so read the syringe markings carefully rather than eyeballing it. Tap out any air bubbles.
4. Clean the site and pinch. Swab the chosen site and let it dry. Pinch a fold of skin and fat between your thumb and forefinger to lift it away from the muscle underneath.
5. Insert and inject. Insert the needle at a 45 to 90 degree angle into the pinched fold. Push the plunger slowly and steadily; a slow push is more comfortable than a fast one. There is no need to aspirate for a subQ injection.
6. Withdraw and apply pressure. Remove the needle at the same angle, release the pinch, and press a clean swab or cotton ball on the spot for a few seconds. Do not rub hard. Drop the syringe straight into the sharps container. Never reuse a needle.
Do Not Inject Into
Avoid tattoos, scars, moles, visible veins, and any skin that is broken, bruised, or irritated. Pick clean skin at least an inch from your last spot.
Rotation Schedule
Injecting the same spot repeatedly causes minor fat-tissue trauma that adds up over weeks. The result is small palpable lumps, occasional bruising, and tissue that absorbs the next dose less predictably. Rotation prevents this.
The rule most providers teach is to move at least one inch, about a finger-width, from your last injection point every time. Within a single region you can work a grid. The abdomen has roughly eight usable spots if you split each side of the navel into quadrants. Cycle through them in order, then move to the next region.
A simple weekly pattern: Monday and Tuesday on the right abdomen, Wednesday and Thursday on the left, Friday on a thigh. Mark the last spot with a fingernail indent if you cannot remember it. After a couple of weeks working the abdomen, give it a rest and rotate through thighs and glutes.
A Note on Dosing
This guide is about where and how, not how much. BPC-157 dosing is set by your provider and depends on your goals and history, and the injection volume is small either way. For how daily dosing and cycle length are typically structured, see the main BPC-157 guide. The one rule that belongs here: draw the exact volume on your prescription, and do not improvise from a number you read in a forum.
Storage
PeRx ships BPC-157 fully reconstituted and ready to use, so there is no mixing step. Store the vial refrigerated at 36 to 46°F (2 to 8°C). Do not freeze it. Keep it upright and away from direct light, and inspect it before each use. The solution should be clear. If it looks cloudy or discolored, do not use it and contact PeRx.
Traveling
Carry BPC-157 in an insulated bag with a small ice pack for trips longer than a few hours. Keep it in your carry-on with your prescription label or a screenshot of your PeRx order. Do not check refrigerated medication.
Safety and When to Call Your Provider
Most people tolerate subcutaneous BPC-157 well, and mild redness or a small bump at the site is common and short-lived. A few things are worth watching for.
Injection-site reactions like a persistent hard lump, spreading redness, warmth, or pus can signal irritation or infection. A little redness that fades in a day is normal; redness that grows is not.
Bruising happens if you nick a small vessel. It is harmless but rotate away from the spot until it clears. Slow, pinched injections reduce it.
Anything systemic such as a rash, hives, dizziness, or trouble breathing is rare, but stop and seek care if it happens. For the fuller picture of what is common versus what deserves a call, see the peptide side effects guide. Your provider prescribed the protocol; if something feels off, reach out rather than adjusting the dose or route on your own.
Do Not Self-Inject Into
Never push a needle into a tendon, joint, or muscle at home. BPC-157 is a subcutaneous injection into the fat layer. Deep or intra-articular injection is a clinical procedure, not a home protocol.
Frequently Asked Questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
BPC-157: Complete Guide to Body Protection Compound
A peptide discovered in a Croatian lab in the early '90s is now one of the most studied healing compounds in regenerative medicine. Here's what the science actually says, where it came from, and what you should know before starting.
Is BPC-157 FDA Approved in 2026? The Honest Answer
No. BPC-157 has never been submitted for FDA approval and has never entered formal clinical trials. It is available as a compounded medication prescribed by licensed providers. Despite being the most widely used peptide in therapy, its entire evidence base comes from preclinical research. Here is what that means and why millions of people use it anyway.
BPC-157 Mechanism of Action
How does BPC-157 actually work? A physician-reviewed walk through the pathways behind its healing effects: angiogenesis through VEGFR2, the EGR-1 early-healing switch, the FAK-paxillin pathway that wakes up tendon cells, and the growth-hormone and nitric-oxide systems. Plus an honest account of what the research shows, and what it does not.
Ready to get started?
Pharmaceutical-grade BPC-157, prescribed by a licensed provider and shipped to your door fully reconstituted and ready to use.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.
Reviewed by Dr. Cory Mellon, MD · Last reviewed July 2026